Navigation Links
Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and,Maintenance vs. Placebo

significance. For TST, the 50 mg dose achieved significance (p=0.024) and the 20 and 100 mg doses showed a trend toward significance.

"VEC-162 induces and maintains sleep by modulating the sleep/wake cycle," said Paolo Baroldi, M.D., Ph.D., Chief Medical Officer, Vanda Pharmaceuticals Inc. "The subjective findings suggest the compound's unique mechanism of action provides a noticeable improvement in overall sleep quality."

About Insomnia

Approximately 70 million American adults experience insomnia of all types, characterized by difficulty falling asleep, waking frequently during the night, waking too early and not being able to return to sleep, or waking up not feeling refreshed. Circadian Rhythm Sleep Disorders (CRSD), one type of insomnia, affect millions of Americans in a number of forms. Shift Worker Sleep Disorder is a CRSD affecting the 14% of Americans who are shift workers. Another CRSD type is Delayed Sleep Phase Syndrome, which affects 5-10% of patients in sleep disorder clinics and accounts for 40% of disorders involving sleep-wake schedules.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc., headquartered in Rockville, Maryland, is a biopharmaceutical company working to advance the science of personalized medicine to improve the lives of patients with various CNS disorders, including insomnia and schizophrenia. The company has three product candidates in clinical development. Vanda's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia and has completed its Phase III program. Vanda's second product candidate, VEC-162, is a compound for the treatment of sleep and mood disorders which is currently in Phase III for insomnia. Vanda's third product candidate, VSF-173, is a compound in Phase II for the treatment of excessive sleepiness. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com .

N
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:8/27/2015)... , Aug. 27, 2015  A mere one ... Booz Allen Hamilton . A new white ... development inefficiencies are impeding and disrupting manufacturers, success. ... Waste and Improve Value In Product Development Processes ... inaccessible data and how it affects the product development ...
(Date:8/27/2015)... , Aug. 27, 2015 NorthStar Anesthesia ... today that it has been selected by Mercy, based in ... services for four of their hospitals:  Mercy St. Vincent  Medical ... Toledo , Mercy St. Charles  Hospital in ... Tiffin . "As we ...
(Date:8/27/2015)... -- According to a new market research ... by Deployment Mode (Web based, On-Premise, Cloud-Based), by End ... by Component - Global Trends & Forecast to 2019", ... $501.1 Million 2014, and is projected to reach $722.7 ... 2014 to 2019. Browse 60 T ...
Breaking Medicine Technology:New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2Four Mercy Hospitals in Northwest Ohio Select NorthStar Anesthesia 2Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4
... March 24, 2011 A new program from American ... consumers regarding the price of advanced diagnostic imaging exams ... are performed, offering significant cost savings and increased satisfaction. ... care spending, there is a growing need for information ...
... PARSIPPANY, N.J., March 24, 2011 PDI, Inc. (Nasdaq: ... NASDAQ Stock Market Closing Bell on Tuesday, March 29, 2011, at ... PDI CEO Nancy Lurker will ring the Closing Bell together with ... "Ringing the NASDAQ bell is a particularly meaningful event for PDI ...
Cached Medicine Technology:American Imaging Management Promotes Affordability and Choice to Health Care Consumers 2American Imaging Management Promotes Affordability and Choice to Health Care Consumers 3American Imaging Management Promotes Affordability and Choice to Health Care Consumers 4
(Date:8/28/2015)... ... 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, a ... carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch that ... Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected by ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... specialist, Dr. James Strawbridge, gives a new approach on solutions in his new ... with the employer and employees getting together for meaningful group meetings. "This would ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... three-year accreditation for its adolescent residential, counseling, day treatment and intensive family based ... meets international standards for quality and its pursuit of excellence. As a nonprofit ...
(Date:8/28/2015)... NY (PRWEB) , ... August 28, 2015 , ... The ... Kybella™. It is the first and only nonsurgical product approved by the Food ... Dr. Vito Quatela and Dr. William Koenig are among the ...
(Date:8/28/2015)... ... 2015 , ... SharkNinja, an innovative leader in the housewares ... Sofia Vergara, and unveil the Ninja® brand’s new coffee machine, the Ninja ... variety of sizes and styles while achieving the perfect brew richness level every ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... EAST LANSING, Mich., Oct. 25 The Board of,Directors ... ),has declared a cash dividend of 10 cents per ... at the close of business on December 13,2007. At ... Corporate Description American Physicians Capital, Inc. is ...
... Calif., Oct. 25 Thoratec,Corporation (Nasdaq: THOR ), ... announced that it will report its operating,results for the ... The company will hold a conference call to ... interested parties at 8:30,a.m., Pacific Daylight Time (11:30 a.m., ...
... tensor imaging can identify structural changes in the white ... even in patients with mild traumatic brain injury. ... of the journal Brain. , "We studied patients ... to severe -- and found that abnormalities in white ...
... Vessel Road Mapping and Magnetic Guidewire Navigation ... Capabilities Demonstrated in Multiple Cases, ST. ... the details of successful, live percutaneous coronary,and peripheral cases ... the Main Arena at the Transcatheter Cardiovascular,Therapeutics (TCT) symposium, ...
... USO has,partnered with CarePages.com to provide wounded troops an ... friends while recovering,in the hospital and at home. Called ... sharing health updates, photos and supportive,messages via a private ... care and support, and allows them to share updates ...
... drugs of tomorrow and how will they be ... Molecular Targets and Cancer Therapeutics, researchers will present ... regarding emerging cancer therapeutics. , New ... cancer tumors, provide tantalizing targets for engineered antibodies ...
Cached Medicine News:Health News:Thoratec Schedules Third Quarter Conference Call, Webcast 2Health News:Imaging shows structural changes in mild traumatic brain injury 2Health News:Imaging shows structural changes in mild traumatic brain injury 3Health News:Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System 2Health News:Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System 3Health News:Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System 4Health News:The USO and CarePages.com Help Wounded Troops Stay Connected to Their Families 2Health News:The USO and CarePages.com Help Wounded Troops Stay Connected to Their Families 3Health News:Targets on the horizon: Emerging therapies and novel targets 2Health News:Targets on the horizon: Emerging therapies and novel targets 3Health News:Targets on the horizon: Emerging therapies and novel targets 4Health News:Targets on the horizon: Emerging therapies and novel targets 5Health News:Targets on the horizon: Emerging therapies and novel targets 6Health News:Targets on the horizon: Emerging therapies and novel targets 7
... camera incorporates a Progressive Scan 1/3" CCD with ... x 768 (V) XGA. Whats more the XCD-X710CR ... called a "Bayer filter") and outputs the "raw ... to be converted to a color image on ...
... Sonys XCD-X710 digital camera incorporates a Progressive ... offers excellent sensitivity (1024 x 768 XGA ... high-resolution, digital B/W images and features an ... exposure range from 1/100,000 to 17.5 second, ...
... The PL-A661 is a monochrome " 1.3 ... microscopy applications. Desgined to simplify real-time ... the PL-A661 provides uncompromising video and digital ... package. The PL-A661 is ideal for industrial ...
... FireWire, high dynamics. Exceptional performance in the ... for your applications: The possibility to respond ... and laboratory work, meeting new challenges with ... been combined with so much flexibility in ...
Medicine Products: